MILAN , Oct. 7, 2024 /PRNewswire/ -- NTC, an international pharmaceutical company headquartered in Milan, Italy , announced today to have embraced a strategic partnership with Silgan Dispensing Systems, a global leading supplier of dispensing solutions in healthcare to commercialize a set of new NTC proprietary eye drops with the innovative Silgan technology Iridya TM , a new preservative free multidose eye dropper. "Thanks to Iridya TM , we improve our innovative dry eye portfolio, pursuing maximum patient satisfaction and compliance", says Marcello Selvaggio , NTC Global Head Ophthalmology .
"We launched the Imperial product line for dry eye offering to our partners a solution that blends the benefits of the other main multidose preservative free devices into one, the Imperial product line, based on our innovative product range" . NTC is going to present the Imperial line during CPhI in Milan , supporting with evidence the innovation of this device characterized by exceptional drop control for precise dosing, elongated tip for a greater accuracy in instillation, and advanced ergonomics to assure a low squeeze force bottle. "We are excited to unleash the potential of the Iridya technology of a leading company like Silgan," – says Riccardo Carbucicchio, CEO of NTC - "The NTC Imperial line is a further proof of NTC's focus on unmet medical needs and its continuous search for innovative solutions.
The Imperial products will enhance the patient experience in dry eye and are de.